William Geist's Insider Trades & SAST Disclosures
William Geist's most recent trade in Bio-Techne Corp was a trade of 3,320 Common Stock done . Disclosure was reported to the exchange on Feb. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William Geist.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,320 | 14,401 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,320 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.55 per share. | 01 Feb 2025 | 1,109 | 13,292 (0%) | 0% | 73.6 | 81,567 | Common Stock |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 9,912 | 9,911 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 9,912 | 14,351 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.31 per share. | 01 Nov 2024 | 3,270 | 11,081 (0%) | 0% | 75.3 | 246,264 | Common Stock |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 21,204 | 21,204 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 15,738 | 15,738 | - | - | Performance Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 7,869 | 7,869 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.54 per share. | 01 Feb 2024 | 1,111 | 7,759 (0%) | 0% | 68.5 | 76,148 | Common Stock |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 30,059 | 30,059 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 24,424 | 24,424 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 22,544 | 22,544 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | Geist William | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 9,074 | 9,074 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 8,377 | 8,377 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 7,400 | 7,400 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 5,550 | 5,550 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne Corp | William Geist | PRESIDENT, PROTEIN SCIENCES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 1,785 | 1,785 | - | - | Restricted Stock Units | |
| Bio-Techne Corp | William Geist | President, Protein Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 2,490 | 2,490 | - | - | Restricted Stock Units | |
| Quanterix Corp | William Geist | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 11,447 | 11,447 | - | - | Stock Option (right to buy) | |
| Quanterix Corp | William Geist | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 4,906 | 44,951 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | William Geist | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2020 | 40,045 | 40,045 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges